On the other hand, research on matrine (MAT), which plays multiple pharmacological roles, found that it protected against cisplatin-induced acute kidney injury (AKI) by antioxidative stress and anti-inflammation actions via the SIRT3/OPA1 pathway [68]. Here, OPA1 is linked to acute kidney injury.